Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
MaaT Pharma announced a capital extension to its series B round, which now totals €25.35 million.

MaaT Pharma announced a capital extension to its series B round, which now totals €25.35 million.

Biotech Health services

France

Switzerland

United States

Investments

01 December 2020

Share:

MaaT Pharma (company)

France

Biotech Health services

Total investments received (USD): 44.76m

Round value (USD): 30.73m

Round investors: Biocodex Bpifrance Céleste Management Sa Crédit Mutuel Innovation Seventure Partners SkyViews Life Science SymBiosis

Company: MaaT Pharma

Industry: Biotech Health services

Related deals

Step Pharma secured €35 million in Series B funding co-led by Hadean Ventures and Sunstone Life Science Ventures.

Biotech Health services

France

Norway

Denmark

Israel

Investments 23 March 2021

InnoSkel raised €20 million in a Series A financing round co-led by Jeito Capital and Vida Ventures.

Biotech Health services

France

United States

Investments 14 December 2020

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top